Skip to Main Content

Paper Details

Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.
Cancer Med
4
2023
CPS, CPS 5, DOT1L, EBV, Epstein-Barr virus, GC, IRS2, LRP1B, MDC1, MET, MSI, PD-L1, PIK3CA, PIK3CA mutations, PTPRT, Programmed death-ligand 1, TET2, gastric cancer, inflamed tumor, metastatic GC, metastatic gastric cancer, microsatellite, patients, programmed death-ligand 1, tumor
Author NameAffiliation
Kyoung-Mee KimSungkyunkwan University School of Medicine, Samsung Medical Center
Sung Tae KimSungkyunkwan University School of Medicine, Samsung Medical Center
Sung Tae KimSungkyunkwan University School of Medicine, Samsung Medical Center
Jeeyun LeeSungkyunkwan University School of Medicine, Samsung Medical Center
  • 1 - 4

Datasets

Release 1.2